Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
- DOI
- 10.1007/s40257-023-00806-3
- Published
- 2023-09-08
- Container
- American Journal of Clinical Dermatology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40257-023-00806-3,
title = {Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials},
author = {Eric L. Simpson and Andrew E. Pink and Andrew Blauvelt and Melinda Gooderham and April W. Armstrong and Margitta Worm and Norito Katoh and Ketty Peris and Luis Puig and Sébastien Barbarot and Thomas Mark and Louise Abildgaard Steffensen and Ann-Marie Tindberg and Andreas Wollenberg},
year = {2023},
journal = {American Journal of Clinical Dermatology},
doi = {10.1007/s40257-023-00806-3},
url = {https://doi.org/10.1007/s40257-023-00806-3}
}RIS
TY - JOUR TI - Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials AU - Eric L. Simpson AU - Andrew E. Pink AU - Andrew Blauvelt AU - Melinda Gooderham AU - April W. Armstrong AU - Margitta Worm AU - Norito Katoh AU - Ketty Peris AU - Luis Puig AU - Sébastien Barbarot AU - Thomas Mark AU - Louise Abildgaard Steffensen AU - Ann-Marie Tindberg AU - Andreas Wollenberg PY - 2023 JO - American Journal of Clinical Dermatology DO - 10.1007/s40257-023-00806-3 UR - https://doi.org/10.1007/s40257-023-00806-3 ER -
APA
Simpson, E. L., Pink, A. E., Blauvelt, A., Gooderham, M., Armstrong, A. W., Worm, M., Katoh, N., Peris, K., Puig, L., Barbarot, S., Mark, T., Steffensen, L. A., Tindberg, A., & Wollenberg, A. (2023). Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials. American Journal of Clinical Dermatology. https://doi.org/10.1007/s40257-023-00806-3
Source records
- crossref · retrieved 2026-09-26T02:43:16.778Z